2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1533):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-121289
    Drazoxolon
    Drazoxolon is an active compound.
    Drazoxolon
  • HY-47878
    WAY-300569
    		98.0%
    N-(3-Fluorophenyl)-3-(4-oxo-5-(thiophen-2-ylmethylene)-2-thioxothiazolidin-3-yl)propanamide is an active molecule.
    WAY-300569
  • HY-P10181
    Acetyl angiotensinogen (1-14), human
    Acetyl angiotensinogen (1-14), human is a synthetic peptide and N-terminal acetylated form of Angiotensinogen (1-14), human (HY-P1486).
    Acetyl angiotensinogen (1-14), human
  • HY-129862
    Eclanamine maleate
    Eclanamine maleate is functionally categorized as a nontricyclic antidepressant.
    Eclanamine maleate
  • HY-W747736
    BVdUMP
    BVdUMP is an active compound.
    BVdUMP
  • HY-W050088R
    Isoxepac (Standard)
    Isoxepac (Standard) (HP 549 (Standard)) is the analytical standard of Isoxepac (HY-W050088). This product is intended for research and analytical applications. Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases.
    Isoxepac (Standard)
  • HY-111205
    γ-Secretase modulator 16
    γ-Secretase modulator 16 is an active compound.
    γ-Secretase modulator 16
  • HY-N4303
    5-​Ethoxy-​10-​Gingerol
    5-​Ethoxy-​10-​Gingerol is a derivate of gingerol.
    5-​Ethoxy-​10-​Gingerol
  • HY-111063
    BX048
    BX048 is an active compound.
    BX048
  • HY-W004292S1
    1-Undecanol-d4
    1-Undecanol-d4 (Undecyl alcohol-d4) is the deuterium labeled 1-Undecanol (HY-W004292). 1-Undecanol (Undecyl alcohol) is the main product generated from the degradation of 2-tridecanone by Pseudomonas bacteria isolated from the soil. 1-Undecanol can enhance the attraction of Grapholita molesta to sex pheromone traps.
    1-Undecanol-d<sub>4</sub>
  • HY-136444
    2-NP-AOZ
    2-NP-AOZ is a 2-nitrophenyl derivative of AOZ (HY-W012982, a tissue-bound metabolite of the Furazolidone). 2-NP-AOZ can be used to determination of the AOZ residues.
    2-NP-AOZ
  • HY-118095
    A60586
    A60586 is an active compound.
    A60586
  • HY-126873
    Nikkomycin J
    Nikkomycin J is an active compound. Nikkomycin J can be used for various researches.
    Nikkomycin J
  • HY-123040
    ACAT Inhibitor 1
    ACAT Inhibitor 1 is an active compound.
    ACAT Inhibitor 1
  • HY-118829
    3,4-Methylenedioxy PV9 hydrochloride
    		99.90%
    3,4-Methylenedioxy PV9 hydrochloride is a Cathinone derivative. 3,4-Methylenedioxy PV9 hydrochloride shows toxicity against BEAS-2B, human aortic endothelia, HASM, SK-N-SH, A172, HepG2, MKN45, and DLD1cells (LC50=12.8-67.5 μM).
    3,4-Methylenedioxy PV9 hydrochloride
  • HY-118709
    Ro 23-7637
    Ro 23-7637 is an orally active, efficacious antiobesity agent.
    Ro 23-7637
  • HY-124423
    ReN 1869
    ReN 1869 is an active compound.
    ReN 1869
  • HY-123170
    PD 099560
    PD 099560 is an active compound.
    PD 099560
  • HY-171456
    PD-224378
    PD-224378 is the lactam form of glycosylamine (β-anomer) formed by the Maillard reaction between pregabalin and lactose.
    PD-224378
  • HY-118727
    6-APDB hydrochloride
    6-APDB hydrochloride is a benzofuran.
    6-APDB hydrochloride